Michael H. Bachmann
Impact in
- Virology top 2%
- HIV Research and Treatment
- Biophysics top 1%
Papers in
-
- bioluminescence and chemiluminescence research 9
- RNA Interference and Gene Delivery 5
- Oncology 16
- CAR-T cell therapy research 8
- Cancer Cells and Metastasis 5
- Co-authors
- Christopher H. Contag (23 shared papers)Robert S. Negrin (7 shared papers)Yu-An Cao (4 shared papers)Matthias Edinger (4 shared papers)Masamitsu Kanada (5 shared papers)Michael R. Verneris (3 shared papers)Jonathan Hardy (3 shared papers)Stefanie Mandl (1 shared paper)
- Journals
- Proceedings of the National Academy of Sciences (3 papers)Cancer Research (3 papers)PLoS ONE (2 papers)Blood (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Michael H. Bachmann
58 papers receiving 5.0k citations
Michael H. Bachmann's Hit Papers
Peers
Comparison fields: 5 of 137
- Virology 370
- Biophysics 287
- Cancer Research 646
- Immunology 824
- Molecular Biology 2.5k
Countries citing papers authored by Michael H. Bachmann
This map shows the geographic impact of Michael H. Bachmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael H. Bachmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael H. Bachmann more than expected).
Fields of papers citing papers by Michael H. Bachmann
This network shows the impact of papers produced by Michael H. Bachmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael H. Bachmann. The network helps show where Michael H. Bachmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael H. Bachmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer Hit paper breakdown → | 2004 | 702 |
| 2 | Advances in In Vivo Bioluminescence Imaging of Gene Expression Hit paper breakdown → | 2002 | 690 |
| 3 | 2015 | 392 | |
| 4 | 2003 | 269 | |
| 5 | 2002 | 260 | |
| 6 | 2002 | 177 | |
| 7 | 1998 | 155 | |
| 8 | 2001 | 154 | |
| 9 | 2007 | 136 | |
| 10 | 2012 | 128 | |
| 11 | 1997 | 125 | |
| 12 | 2002 | 116 | |
| 13 | 2001 | 114 | |
| 14 | 2005 | 108 | |
| 15 | 2016 | 104 | |
| 16 | 2018 | 100 | |
| 17 | 2012 | 97 | |
| 18 | 2015 | 95 | |
| 19 | 2014 | 93 | |
| 20 | 2005 | 82 |
About Michael H. Bachmann
Michael H. Bachmann is a scholar working on Molecular Biology, Oncology, Immunology, Biomedical Engineering and Genetics, having authored 58 papers that have together received 5.1k indexed citations. Recurring topics across this work include bioluminescence and chemiluminescence research (9 papers), Virus-based gene therapy research (8 papers), CAR-T cell therapy research (8 papers), HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (6 papers), RNA Interference and Gene Delivery (5 papers), Cancer Cells and Metastasis (5 papers) and Immunotherapy and Immune Responses (5 papers). The work is most often cited by research in Virology (370 citations), Biophysics (287 citations), Cancer Research (646 citations), Immunology (824 citations) and Molecular Biology (2.5k citations). Michael H. Bachmann has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Christopher H. Contag, Robert S. Negrin, Yu-An Cao, Matthias Edinger, Masamitsu Kanada, Michael R. Verneris, Jonathan Hardy, Stefanie Mandl, Dean W. Felsher and Catherine M. Shachaf. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cancer Research, PLoS ONE, Blood and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.